SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-410208
Filing Date
2014-11-13
Accepted
2014-11-13 07:01:54
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d801705d10q.htm 10-Q 272454
2 EX-31.1 d801705dex311.htm EX-31.1 5732
3 EX-32.1 d801705dex321.htm EX-32.1 2964
  Complete submission text file 0001193125-14-410208.txt   2825669

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rxii-20140930.xml EX-101.INS 357197
5 XBRL TAXONOMY EXTENSION SCHEMA rxii-20140930.xsd EX-101.SCH 23081
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20140930_cal.xml EX-101.CAL 38979
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20140930_def.xml EX-101.DEF 109687
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20140930_lab.xml EX-101.LAB 228535
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20140930_pre.xml EX-101.PRE 184052
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 141216268
SIC: 2834 Pharmaceutical Preparations